PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A
β Scribed by Yi-Hong Zhou; Yuanjie Hu; Debra Mayes; Eric Siegel; Jae G. Kim; Marlon S. Mathews; Nelson Hsu; Daniel Eskander; Ong Yu; Bruce J. Tromberg; Mark E. Linskey
- Publisher
- Springer US
- Year
- 2009
- Tongue
- English
- Weight
- 447 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Recent studies have shown that several angiogenic growth factors are produced and secreted by normal endocrine cells and are increased in pathological states of endocrine glands, including inflammation, hyperplasia, and neoplasia. Expression of corresponding receptors on epithelial cell
histologic features on hematoxylin and eosin stained sections, and microvessel density and distribution using sections immunostained for factor VIII-related anti-1 Departments of Pathology, Beth Israel Deagen. In addition, in situ hybridization was performed on formalin fixed, paraffin coness Medica
Angiogenesis is a possible target in the treatment of human gliomas. To evaluate the role of 3 growth factors, vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF) and basic fibroblast growth factor (bFGF), in the angiogenic cascade, we determined their levels